Alerts will be sent to your verified email
Verify EmailAAYUSH
Aayush Wellness
|
Zenotech Laboratorie
|
Nectar Lifesciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-4.78 % | 7.83 % | -0.71 % |
5yr average Equity Multiplier
|
3.4 | 1.26 | 2.17 |
5yr Average Asset Turnover Ratio
|
2.08 | 0.33 | 0.74 |
5yr Avg Net Profit Margin
|
15.89 % | -17.58 % | -0.63 % |
Price to Book
|
39.24 | 3.33 | 0.34 |
P/E
|
76.12 | 60.91 | 0.0 |
5yr Avg Cash Conversion Cycle
|
406.01 Days | 36.89 Days | 81.28 Days |
Inventory Days
|
56.86 Days | 145.01 Days | 136.26 Days |
Days Receivable
|
406.01 Days | 61.38 Days | 62.43 Days |
Days Payable
|
90.96 Days | 477.06 Days | 113.03 Days |
5yr Average Interest Coverage Ratio
|
394.43 | -4.03 | 0.94 |
5yr Avg ROCE
|
4.61 % | 7.95 % | 7.51 % |
5yr Avg Operating Profit Margin
|
8.22 % | 4.66 % | 7.57 % |
5 yr average Debt to Equity
|
0.63 | 0.12 | 0.73 |
5yr CAGR Net Profit
|
-1.67 % | n/a | -31.15 % |
5yr Average Return on Assets
|
-2.49 % | 7.07 % | -0.34 % |
Shareholdings
|
|||
Promoter Holding
|
0.0 | 68.84 % | 44.53 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 99.6 % |
Change in Promoter Holding (3 Yrs)
|
-32.52 % | 0.0 | -11.27 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Aayush Wellness
|
Zenotech Laboratorie
|
Nectar Lifesciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|